Prospective Study for NaturalVue Multifocal Demonstrates Decreased Refractive Error Change in Fast-Progressing Myopic Children

ATLANTA--(BUSINESS WIRE)--Thomas Aller, OD, FBCLA, an internationally recognized expert in nearsightedness in children, has presented updated findings from a prospective clinical trial of NaturalVue® (etafilcon A) 1 Day Multifocal Contact Lenses from Visioneering Technologies, Inc. Dr. Aller presented the data at the American Academy of Optometry (AAO) Conference in San Antonio Texas on November 9. Dr Aller, who is a practicing optometrist and Visiting Scholar at the UC Berkeley School of Optom

Full Story →